The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhlGF-I)

Clinical Endocrinology

Volumn 46, Issue 4, 1997, Pages 415-424

  Cheetham, Tim D ^a,b   Connors, Matthew ^a   Clayton, Kharen ^a   Watts, Angie ^a   Dunger, David B ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLYCOSYLATED HEMOGLOBIN; GROWTH HORMONE; INSULIN; ISOPHANE INSULIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HEMOGLOBIN DETERMINATION; HORMONAL REGULATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030967269     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.1320953.x     Document Type: Article

References (45)

1. Albertsson-Wikland, K. & Rosberg, S. (1992) Reproducibility of 24-h growth hormone profiles in children. Acta Endocrinologica, 126, 109-112.
2. Åman, J., Kroon, M., Karlsson, I. & Hagenäs, L. (1996) Reduced growth hormone secretion improves insulin sensitivity in adolescent girls with diabetes. Acta Paediatrica, 85, 31-37
3. Amiel, S.A., Sherwin, R.S., Simonson, D.V., Laumtano, A.A. & Tamborlane, W.V. (1986) Impaired insulin action in puberty. A contributing factor to poor glycaemic control in adolescents with diabetes. New England Journal of Medicine, 315, 215-219.
4. Arslanian, S., Heil, B.V. & Kalhan, S.C. (1993) Hepatic insulin action in adolescents with insulin-dependent diabetes mellitus: relationship with long-term glycaemic control. Metabolism, 42, 283-290.
5. Bach, M.A., Chin, E. & Bondy, C.A. (1994) The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 79, 1040-1045.
6. Batch, J.A. & Werther, G.A. (1992) Changes in growth hormone concentrations during puberty in adolescents with insulin dependent diabetes. Clinical Endocrinology, 36, 411-416.
7. Beaufrere, B., Beylot, M., Metz, C., Ruitton, A., Francois, R., Riou, J.P. & Mornex, R. (1988) Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion. Diabetologia, 31, 607-611.
8. Bermann, M., Jaffe, C.A., Wellington, T., DeMott-Friberg, R. & Barkan, A.L. (1994) Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Journal of Clinical Investigation, 94, 138-145.
9. Bolinder, J., Lindblab, A., Engfeldt, P. & Arner, P. (1987) Studies of acute effects of insulin-like growth factors I and II in human fat cells. Journal of Clinical Endocrinology and Metabolism, 65, 732-737.
10. Caprio, S., Plewe, G., Diamond, M.P., Simonson, D.C., Boulware, S.D., Sherwin, R.S. & Tamborlane, W.V. (1989) Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. Journal of Pediatrics, 114, 963-967.
11. Ceda, G.P., Davis, R.G., Rosenfeld, R.G. & Hoffman, A.R. (1987) The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Endocrinology, 120, 1658-1662.
12. Cheetham, T.D., Jones, J., Taylor, A.M., Holly, J., Matthews, D.R. & Dunger, D.B. (1993) The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with Type I (insulin-dependent) diabetes mellitus. Diabetologia, 36, 678-681.
13. Cheetham, T.D., Clayton, K.L., Taylor, A.M., Holly, J., Matthews, D.R. & Dunger, D.B. (1994) The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus. Clinical Endocrinology, 40, 515-522.
14. Donaldson, D.L., Hollowell, J.G., Pan, F., Gifford, R.A & Moore, W.V. (1989) Growth hormone secretory profiles: variation on consecutive nights. Journal of Pediatrics, 115, 51-56.
15. Dozio, N., Scavini, M., Beretta, A., Sartori, S., Meschi, F., Sarugeri, E. & Pozza, G. (1995) In vivo metabolic effects of insulin-like growth factor-I not mediated through the insulin receptor. Journal of Clinical Endocrinology and Metabolism, 80, 1325-1328.
16. Edge, J.A., Dunger, D.B., Matthews, D.R., Gilbert, J.P. & Smith, C.P. (1990a) Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. Journal of Clinical Endocrinology and Metabolism, 71, 1356-1362.
17. Edge, J.A., Matthews, D.R. & Dunger, D.B. (1990b) The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics. Clinical Endocrinology, 33, 729-737.
18. Fowelin, J., Attvall, S., von Schenck, H., Smith, U. & Lager, I. (1991) Characterization of the insulin antagonistic effect of growth hormone in man. Diabetologia, 34, 500-506.
19. Hartman, M.L., Clayton, P.E., Johnson, M.L., Celniker, A., Pearlman, A.J., Alberti, K.G.M.M. & Thorner, M.O. (1993) A low dose euglycaemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. Journal of Clinical Investigation, 91, 2453-2462.
20. Hindmarsh, P., Di Silvio, L., Pringle, P.J., Kurtz, A.B. & Brook, C.G.D. (1988) Changes in serum insulin concentration during puberty and their relationship to growth hormone. Clinical Endocrinology, 28, 381-388.
21. Ho, K.Y., Veldhuis, J.D., Johnson, M.L., Furlanetto, R. & Evans, W.S. (1988) Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. Journal of Clinical Investigation, 81, 968-975.
22. Ismail, I.S., Scanlon, M.F. & Peters, J.R. (1991) Effects of ambient glycaemic state on growth hormone responsiveness in insulin-dependent diabetes. Clinical Endocrinology, 35, 499-504.
23. Laager, R., Ninnis, R. & Keller, U. (1993) Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans. Journal of Clinical Investigation, 92, 1903-1909.
24. Massa, G., Dooms, L., Bouillon, R. & Vanderschureren-Lodeweyckx, M. (1993) Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 36, 239-243.
25. Matthews, D.R., Edge, J.R. & Dunger, D.B. (1990) An unbiased glucose clamp method using a variable insulin infusion:its application in diabetic adolescents. Diabetic Medicine, 7, 246-251.
26. Mellanby, J. & Williamson, D.H. (1974) Acetoacetate. In: Methods of Enzymatic Analysis. (ed. H.V. Bergmayer) Vol. 4, pp. 1840-1843. Academic Press, New York.
27. Merriam, G.R. & Wachter, K.W. (1982) Algorithms for the study of episodic hormone secretion. American Journal of Physiology, 243, E310-18.
28. Metcalfe, P., Johnston, D.G., Nosadini, R., Orksov, H. & Alberti, K.G.M.M. (1981) Metabolic effects of acute and prolonged growth hormone excess in normal and insulin-deficient man. Diabetologia, 20, 123-128.
29. Mokan, M. & Gerich, J.E. (1992) A simple insulin infusion algorithm for establishing and maintaining overnight near-euglycaemia in Type I and Type II diabetes. Journal of Clinical Endocrinology and Metabolism, 74, 943-945.
30. Morgan, C.R. & Lazarow, A. (1963) Immunoassay of insulin: two antibody system. Diabetes, 12, 115-126.
31. Pal, B.R., Phillips, P.E., Matthews, D.R. & Dunger, D.B. (1992) Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin - dependent) diabetes mellitus. Diabetologia, 35, 542-549.
32. Pal, B.R., Matthews, D.R., Edge, J.A., Mullis, P.E., Hindmarsh, P.C. & Dunger, D.B. (1993) The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia. Clinical Endocrinology, 38, 93-100.
33. Perriello, G., De Feo, P., Torlone, E., Fanelli, C., Santeusanio, F., Brunetti, P. & Bolli, G.B. (1990) Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type-1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia, 33, 52-59.
34. Perriello, G., De Feo, P., Torlone, E., Fanelli, C., Santeusanio, F., Brunetti, P. & Bolli, G.B. (1991) The dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia, 34, 21-28.
35. Press, M., Caprio, S., Tamborlane, W.V., Bhushan, R., Thorner, M., Vale, W., Rivier, J. & Sherwin, R.S. (1992) Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes, 41, 17-21.
36. Rizza, R.A., Mandarine, L.J. & Gerich, J.E. (1982) Effects of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes, 31, 663-669.
37. Sherwin, R.S., Schulman, G.A., Hendler, R., Walesky, M., Belous, A. & Tamborlane, W. (1983) Effect of growth hormone on oral glucose tolerance and circulating metabolic fuels in man. Diabetologia, 24, 155-161.
38. Smith, C.P., Archibald, H.R., Thomas, J.M., Tarn, A.C., Williams, A.J.K., Gale & E.A.M., Savage, M.O. (1988) Basal and stimulated insulin levels rise with advancing puberty. Clinical Endocrinology, 28, 7-14.
39. Tanner, J.M. (1962) Growth at Adolescence. Oxford, Blackwell.
40. Taylor, A.M., Dunger, D.B., Grant, D.B. & Preece, M.A. (1988) Somatomedin-C/IGF-1 measured by radioimmunoassay and somatomedin bioactivity in adolescents with insulin dependent diabetes compared with puberty matched controls. Diabetes Research, 9, 177-181.
41. Taylor, A.M., Dunger, D.B., Preece, M.A., Holly, J.M.P., Smith, C.P., Wass, J.A.H., Patel, S. & Tate, V.E. (1990) The growth hormone independent insulin-like growth factor I binding protein BP-28 is associated with serum insulin-like growth factor I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clinical Endocrinology, 32, 229-239.
42. Trainer, P.J., Holly, J., Medbak, S. & Besser, G.M. (1993) Effect of recombinant insulin-like growth factor I on anterior pituitary function in healthy volunteers. Acta Paediatrica Scandinavica, 388, 38-39.
43. Williamson, D.H. & Mellanby J. (1974) D-(-)-3-Hydroxybutyrate. In: Methods of Enzymatic Analysis (ed: H.V. Bergmayer) Vol. 4, pp. 1836-1839. Academic Press, New York.
44. Wurzburger, M.I., Prelevic, G.M., Sonksen, P.H., Peric, L.A., Till, S. & Morris, R.W. (1990) The effects of improved blood glucose control on growth hormone and cortisol secretion in insulin-dependent diabetes mellitus. Clinical Endocrinology, 32, 787-797.
45. Zenobi, P.D., Silvia, E., Jaeggi-Groisman, S., Riesen, W.F., Roder, M.E. & Froesch, E.R. (1992) Insulin-like growth factor-I improves glucose and lipid metabolism in Type 2 diabetes mellitus. Journal of Clinical Investigation, 90, 2234-2241.